IPharm OECD Good Laboratory Practice compliance certificate IPharm OECD Good Laboratory Practice compliance certificate

  Current Achievement

IPharm obtains OECD Good Laboratory Practice compliance certificate

IPharm is proud to be Good Laboratory Practice (GLP) compliant. The OECD GLP certificate was awarded in July 2018 by National Pharmaceutical Regulatory Agency, Ministry of Health. IPharm is now a GLP compliant test facility, which the test results are accepted not only in OECD countries (including European countries, Japan, Korea and USA) but also in countries which adhere to the OECD's Mutual Acceptance of Data system, i.e. Argentina, Brazil, India, Malaysia, Singapore and South Africa. The certification reduces duplicative testing, saves laboratory costs, promotes work-sharing by countries assessing the same data and removes a potential non-tariff trade barrier.

Malaysia government has been taking effort to promote quality, safety and efficacy in pharmaceuticals. Starting 2018, registration of New Chemical Entity (NCE), biologics, herbal products with high therapeutic claims is required to fulfil GLP requirements in non-clinical safety studies. IPharm's GLP compliant studies currently cover toxicology for products under category of pharmaceuticals, cosmetics, veterinary drugs and food additives. With the GLP certification, IPharm is capable to provide non-clinical testings that are world-class standard. IPharm will continue to provide cost effective services for companies to meet the regulatory needs for both local and export market in compliance to OECD Principles of GLP, hence the companies will be able to register and export their products globally.

Procurement Detail:


Submission Deadline : 2017-07-13

Membekal, menghantar, memasang,integrasi, menguji dan mentauliah sistem pemprosesan, analitik dan  pangkalan data myNature 50000 bagi Institut Farmaseutikal dan Nutraseutikal Malaysia (IPharm), National  Institutes of Biotechnology Malaysia (NIBM)

More information...

Quotation Notice

Submission Deadline : 2017-09-22

Membekal, Menghantar, Memasang, Menguji Dan Mentauliah Satu (1) Unit Fluorescent Microscope with Camera Untuk Projek Flagship Enhancing the Therapeutic of raf Newcastle Disease Virus Cancer Vaccine Di Institut Genom Malaysia, National Institutes Of Biotechnology Malaysia (NIBM). 

More information...

Job Opportunities/Career Detail:

Submission Deadline : 2018-07-27
Pembantu Akaun Gred 13 untuk Jawatan Kontrak di Pejabat Pengurusan Korporat, NIBM Serdang,Malaysia

More information...

Submission Deadline : 2018-07-16
Pengurus Akaun dan Kewangan Gred 5 untuk Jawatan Tetap di Pejabat Pengurusan Korporat, NIBM Serdang,Malaysia

More information...

  Corporate Profile

IPharm aim to be a Biotechnology's Centers of Excellence by exploiting megadiversity of Malaysian natural resources for the development of new drugs. IPharm therefore has a mission to conduct world-class R&D to accelerate the discovery, development and commercialization of pharmaceutical and nutraceutical products.


Title :
A Study on The Potential of Active Contituent from Senna Spectabilis in Treating Leishmania Major Infection

More information...